KAVA CRM vs Pharmaid: Revenue, Funding & Team Size Compared
Last updated
KAVA CRM generates $660K in revenue; Pharmaid generates $686K. Pharmaid and KAVA CRM are close to the same size by revenue. The table below compares KAVA CRM and Pharmaid on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $660K | $686K |
| Valuation | Not disclosed | $613.5K |
| Funding raised | Not disclosed | $61.4K |
| Team size | 6 | 4 |
| Founded | 2013 | 2016 |
| HQ | Sydney, Australia | Embourg, Belgium |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
KAVA CRM at a glance
KAVA CRM generates $660K in revenue with 6 employees, headquartered in Sydney, Australia.
- Revenue
- $660K
- Team size
- 6
- Founded
- 2013
KAVA CRM is a cloud-based CRM system designed specifically for insurance brokers to manage all aspects of client-facing activities - from managing new business leads to renewing policies and managing claims. One solution for your entire…
Pharmaid at a glance
Pharmaid generates $686K in revenue with 4 employees, headquartered in Embourg, Belgium.
- Revenue
- $686K
- Valuation
- $613.5K
- Funding
- $61.4K
- Team size
- 4
- Founded
- 2016
SaaS, Pharmaceutical social network, BtoB
Other KAVA CRM alternatives
KAVA CRM competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
KAVA CRM vs Pharmaid: frequently asked questions
Is KAVA CRM or Pharmaid bigger?
Pharmaid is the bigger company by revenue, at $686K against $660K for KAVA CRM.
How much revenue does KAVA CRM make?
KAVA CRM generates $660K in annual revenue with a team of 6.
How much revenue does Pharmaid make?
Pharmaid generates $686K in annual revenue with a team of 4.
How much funding has Pharmaid raised?
Pharmaid has raised $61.4K in total funding since it was founded in 2016.